Dr. McPherson’s research group, based on the Sacramento Campus, is interested: in understanding the mechanisms underlying structural rearrangements in tumors; in bringing advanced genomic technologies to clinical application in personalized diagnosis and targeted therapeutics through maximizing the data yield from small biopsies and circulating cell free DNA; and in reducing chemotherapy-induced side effects during cancer treatment.
